Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Protagonist Therapeutics, Inc | ptgx-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Protagonist Therapeutics, Inc | ptgx-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Protagonist Therapeutics, Inc | ptgx-20201231xex31d1.htm |
| EX-23.1 - EX-23.1 - Protagonist Therapeutics, Inc | ptgx-20201231xex23d1.htm |
| EX-21.1 - EX-21.1 - Protagonist Therapeutics, Inc | ptgx-20201231xex21d1.htm |
| EX-4.7 - EX-4.7 - Protagonist Therapeutics, Inc | ptgx-20201231xex4d7.htm |
| 10-K - 10-K - Protagonist Therapeutics, Inc | ptgx-20201231x10k.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-237066, No. 333-230213, No. 333-213120, No. 333-216532, No. 333-223500 and No. 333-225294) and Form S-3 (No. 333-251254, No. 333-227216 and No. 333-234414) of Protagonist Therapeutics of our report dated March 10, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, CA
March 10, 2021